Trends in Molecular Medicine: The RB protein: more than a sentry of cell cycle entry (Sung Lab)
May 1, 2025
Pulari U. Thangavelu1,11 ∙ Cheng-Yu Lin1,11 ∙ Farzaneh Forouz2 ∙ Kozo Tanaka3 ∙ Eloïse Dray4,5,6 ∙ Pascal H.G. Duijf7,8,9,10 pascal.duijf@unisa.edu.au Highlights The retinoblastoma protein (RB) signal transduction pathway suppresses tumor development and is impaired in most cancers. RB pathway disruption in tumors promotes a broad range of malignant properties, such as cancer-associated blood vessel formation, metastasis, inflammation, immune evasion, cell survival, and metabolic reprogramming, as well as genomic instability. Impaired RB pathway [...]